1,451
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis

, , , , , , , & show all
Pages 2433-2437 | Received 21 Apr 2014, Accepted 29 May 2014, Published online: 19 Jun 2014

References

  • World Health Organization. Rabies vaccines: WHO position paper, Weekly Epidemiological Record, No. 32. 2010; 85:309 - 20
  • World Health Organization. WHO expert consultation on rabies. Technical report series 982. WHO Geneva, 2013.
  • World Health Organization. WHO expert consultation on rabies. TRS 931. WHO Geneva 2005.
  • Sudarshan MK, Madhusudana SN, Mahendra BJ, Rao NS, Ashwath Narayana DH, Abdul Rahman S, Meslin F-, Lobo D, Ravikumar K, Gangaboraiah. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis 2007; 11:29 - 35; http://dx.doi.org/10.1016/j.ijid.2005.10.007; PMID: 16678463
  • Sudarshan MK, Mahendra BJ, Madhusudana SN, Ashwoath Narayana DH, Rahman A, Rao NS, X-Meslin F, Lobo D, Ravikumar K, Gangaboraiah. An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey. J Commun Dis 2006; 38:32 - 9; PMID: 17370688
  • Ravish HS, Srikanth J, Ashwath Narayana DH, Annadani R, Vijayashankar V, Undi M. Pre-exposure prophylaxis against rabies in children: safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route. Hum Vaccin Immunother 2013; 9:1910 - 3; http://dx.doi.org/10.4161/hv.25203; PMID: 23787889
  • Ashwath Narayana DH, Madhusudana SN, Sampath G, Tripathy RM, Sudarshan MK, Gangaboraiah, Ravish HS, Satapathy DM, Gowda G, Holla R, et al. Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India. Hum Vaccin Immunother 2014; 10:120 - 5; http://dx.doi.org/10.4161/hv.26456; PMID: 24030586
  • Smith JS, Yager PA, Baer GM. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody. In: Meslin FX, Kaplan MM, Koprowski H, editors. Laboratory techniques in rabies. 4th ed. World Health Organization; 1996.
  • Plotkin SA, Koprowski H, Rupprecht CE. Rabies vaccines. In: Plotkin SA, Orensterin WA, Offit PA, eds. Vaccines, 5th edition, Saunders Elsevier, 2008, 687-714.
  • Barth R, Gruschkau H, Bijok U, Hilfenhaus J, Hinz J, Milcke L, Moser H, Jaeger O, Ronneberger H, Weinmann E. A new inactivated tissue culture rabies vaccine for use in man. Evaluation of PCEC-vaccine by laboratory tests. J Biol Stand 1984; 12:29 - 46; http://dx.doi.org/10.1016/S0092-1157(84)80019-0; PMID: 6199357
  • Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S. Dumavibhat, Tongswas S. Antibody response of patients after post exposure vaccination with small intradermal dose of purified chick embryo cell rabies vaccine or purified vero cell rabies vaccine. Bull World Health Organ 2000; 78:693 - 8; PMID: 10859864
  • Finke S, Karger A, Freuling C, Müller T. Assessment of inactivated human rabies vaccines: biochemical characterization and genetic identification of virus strains. Vaccine 2012; 30:3603 - 9; http://dx.doi.org/10.1016/j.vaccine.2012.03.047; PMID: 22469862

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.